Professor, Medicine, University of Washington School of Medicine
Oncology
Dr. H J. Deeg, MD
|
|
Give Review
Doctor H J. Deeg, MD practices Oncology. Deeg is a published physician as well. He has 98 publications published. The latest was: Hematopoietic Cell Transplantation as Curative Therapy forPatients with Myelofibrosis: Long-Term Success in all AgeGroups.
Publications
- Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.
- Myelodysplastic syndromes, version 2.2015.
- Role of Hematopoietic Stem Cell Transplantation in Patients with Myeloproliferative Disease.
- Myelodysplastic syndrome evolving from aplastic Anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation.
- Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter Trial.
- α-1-antitrypsin (AAT)-modified donor Cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics.
- Number of Courses of Induction Therapy Independently Predicts Outcome after Allogeneic Transplantation for AML in First Morphological Remission.
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis.
- Pre-transplant comorbidities predict severity of Acute graft-versus-host disease and subsequent mortality.
- Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelody...
- Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic Cell transplantation.
- Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis.
- Murine xenogeneic models of myelodysplastic syndrome: An essential role for stroma Cells.
- Transplantation for Myelodysplastic syndromes 2013.
- Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic Anemia.
- Hematopoietic stem Cell transplantation for older patients with myelodysplastic syndromes.
- Allogeneic transplantation, fas signaling, and dysregulation of hepcidin.
- Outcomes of allogeneic hematopoietic Cell transplantation in patients with dyskeratosis congenita.
- Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic Cell transplantation: pharmacokinetics and clinical outcomes.
- Role of reduced-intensity conditioning allogeneic hematopoietic stem-Cell transplantation in older patients with de novo myelodysplastic syndromes: an international co...
- Components of the revised International Prognostic Scoring System and outcome after hematopoietic Cell transplantation for myelodysplastic syndrome.
- Dissecting graft-versus-Leukemia from graft-versus-host-disease using novel strategies.
- Graft-versus-host disease and Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.
- Transcriptional regulation of miR-10a/b by TWIST-1 in Myelodysplastic syndromes.
- Neuroimmunomodulation and aging: a role for transferrin and the hypothalamus/thymus axis.
- Proteomic Classification of Acute Leukemias by Alignment-Based Quantitation of LC-MS/MS Data Sets.
- Allogeneic hematopoietic Cell transplantation for MDS: For whom, when and how?
- Treatment of therapy-related MDS-It is worth a try!
- Allogeneic hematopoietic Cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.
- Allogeneic hematopoietic Cell transplantation for myelodysplastic syndrome: the past decade.
- Patterns of blood product use among patients with Myelodysplastic syndrome.
- Late effects among pediatric patients followed for nearly four decades after transplantation for severe aplastic Anemia.
- Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic Cell transplantation.
- Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem Cell transplantation.
- A Retrospective Comparison of Tacrolimus versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation with Mobilized...
- Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic Cell transplantation for high-risk hematologic malignancies.
- Optimization of therapy for severe aplastic Anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on sev...
- Treatment-related Myelodysplastic syndrome: molecular characteristics and therapy.
- NCCN Clinical Practice Guidelines in Oncology: Myelodysplastic syndromes.
- Tp53 codon-72 polymorphisms identify different radiation sensitivities to g2-chromosome breakage in human lymphoblast Cells.
- Pharmacogenetics of Intravenous and Oral Busulfan in Hematopoietic Cell Transplant Recipients.
- Who is fit for allogeneic transplantation?
- Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous Leukemia, indepe...
- Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival is Determined by Karyotype and Comorbidities.
- Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic Anemia in patients over 40 years of age.
- Impact of recipient statin treatment on Graft-versus-host disease after allogeneic hematopoietic cell transplantation.
- Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington State, 2005-2006.
- The helix-loop-helix transcription factor TWIST is dysregulated in Myelodysplastic syndromes.
- Hematopoietic stem Cell transplantation for MDS.
- Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide Analysis.
- Life expectancy in patients surviving more than 5 years after hematopoietic Cell transplantation.
- Donor statin treatment protects against severe Acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.
- Myelodysplastic syndromes: from neglect to prominence.
- Allogeneic hematopoietic Cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients...
- NCCN Task Force: Transfusion and iron overload in patients with Myelodysplastic syndromes.
- Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS.
- Pomalidomide is active in the treatment of Anemia associated with myelofibrosis.
- 59-year-old man with MDS.
- Transplantation conditioning regimens: can we say it better?
- Longitudinal assessment of morbidity and Acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter p...
- Risk factors for lymphoproliferative Disorders after allogeneic hematopoietic cell transplantation.
- Initial therapy of Acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
- Allogeneic hematopoietic Cell transplantation for patients with myelofibrosis.
- Transplantation of allogeneic T Cells alters iron homeostasis in NOD/SCID mice.
- The role of cytotoxic therapy with hematopoietic stem Cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
- Basal cell skin Cancer after total-body irradiation and hematopoietic cell transplantation.
- Solid Cancers after allogeneic hematopoietic cell transplantation.
- Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.
- Red blood Cell transfusion dependence and outcome after allogeneic peripheral blood stem Cell transplantation in patients with de novo myelodysplastic syndrome (MDS).
- Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with Myelodysplastic syndrome.
- Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2.
- Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with Myelodysplastic syndromes.
- Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of Graft-versus-host disease following hematopoietic cell transplantation fro...
- Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic Leukemia modulates apoptosis and impairs NK function.
- Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk Myelodysplastic syndromes with karyotypes other than deletion 5q.
- Gene expression patterns in myelodyplasia underline the role of apoptosis and differentiation in Disease initiation and progression.
- Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with Acute myeloid leukemia in first remission: combined FHCRC and M...
- Comorbidity and disease status based risk stratification of outcomes among patients with Acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic ce...
- Hematopoietic cell transplantation in patients with myelodysplastic syndrome or Acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patie...
- Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic Cell transplantation: pharmacokinetics, liver toxicity, and mortality.
- How I treat refractory Acute GVHD.
- Hematopoietic Cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
- Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or Acute myeloid leukemia with multilineage dysplasia.
- Regression of myelofibrosis and osteosclerosis following hematopoietic Cell transplantation assessed by magnetic resonance imaging and histologic grading.
- Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic Anemia after failure of immunosuppressive therapy.
- Transplantation and aging.
- Reduced incidence of Acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
- Evidence of donor-derived hematologic malignancies after hematopoietic stem Cell transplantation.
- Nonmelanoma skin and mucosal Cancers after hematopoietic cell transplantation.
- Transplant strategies for patients with Myelodysplastic syndromes.
- Myelodysplastic syndromes clinical practice guidelines in oncology.
- Protection of human and murine hepatocytes against Fas-induced death by transferrin and iron.
- The clinical spectrum of Acute graft-versus-host disease.
- NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in Myelodysplastic syndromes (MDSs).
- Diagnosis and treatment of children with aplastic Anemia.
- Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of Graft-versus-host dise...
- Allogeneic hematopoietic cell transplantation for chronic myelomonocytic Leukemia.
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Bonn Faculty of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184847469 |
| Last Name Of The Provider | DEEG |
| First Name Of The Provider | H |
| View All |
Similar Doctors
|
|
Dr. Edmond A. Marzbani, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel B. Martin, MD |
|
|
Dr. Anthony L. Back, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joe Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Gwin III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul E. Neiman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J S. Tolman, MD |
|
|
Dr. Kristine J. Rinn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew L. Coveler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George E. Georges, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kim A. Margolin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cassian K. Yee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian G. Till, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Veena Shankaran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil R. Hingorani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward H. Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew S. Sandler, MD
This Doctor is OpenDoctor Recommended.
|